The Continuing Impact of the COVID-19 Pandemic on Diabetic Retinopathy Screenings

This retrospective observational study of health claims data seeks to quantify the prolonged impact of the COVID-19 pandemic on DR screening rates in central Massachusetts. Retrospective claims data from the UMass Memorial Managed Care Network were collected for the years of 2018-2022. Comprehensive...

Full description

Saved in:
Bibliographic Details
Published in:Ophthalmic epidemiology 2024-07, p.1-7
Main Authors: Bilsbury, Evan, Mautner Wizentier, Marina, Wood, Emma, Doherty, Sean, Ledwith, James, Ding, Juan
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This retrospective observational study of health claims data seeks to quantify the prolonged impact of the COVID-19 pandemic on DR screening rates in central Massachusetts. Retrospective claims data from the UMass Memorial Managed Care Network were collected for the years of 2018-2022. Comprehensive and DR screening exams were identified using CPT codes for patients with diabetes. Data were derived from claims submitted by the UMass Memorial Managed Care network to four insurance programs via CPT billing code for comprehensive and DR screening exams for patients with diabetes. Over one million claims for the years 01/2018-05/2022 were collected. We found a significant decrease in unadjusted DR screening rates in the post-lockdown period compared to the pre-COVID-19 period (  
ISSN:0928-6586
1744-5086
1744-5086
DOI:10.1080/09286586.2024.2372045